GNI GROUP LTD.
Contact Us
About Us
About Us TOP
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate governance
R&D
R&D TOP
Pipeline
Discovery Research
Research publications
Investor Relations
Investor Relations TOP
IR News
Information
IR Materials
IR Calendar
IR Email Subscription
Electronic Public Notices
Sustainability/ESG
Sustainability/ESG TOP
Sustainability Initiatives
ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー
2012's Information
トップページ
Information
2012年
All
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2012/11/29
The Beijing Evening News channel visited Beijing Continent Pharmaceuticals for its pirfenidone product development program and interviewed Dr. Ying Luo.
2012/10/30
G20 Innovation Award
2012/10/17
F351 clinical trial for liver fibrosis
2012/06/18
BIO2012
2012/06/12
Patent Allowance for Pirfenidone/F647 and its Derivative’s Use in Radiation-Caused Lung Injury
2012/06/04
Notice of Subsidiary Company Establishment of Shanghai Genomics Inc.
2012/04/30
The China Pharmaceutical & Biotechnology Review, a monthly publication covering all aspects of the industry (2012 volume 58), published a panel discussion with Dr. Ying Luo and other Experts from biotechs and research institutes in China.
2012/03/16
Research Findings of F573 Published
2012/03/11
Drug Discovery World Asia 2012
2012/02/29
Notice for Manufacturing and Distribution Permission regarding IPF treatment drug, F647
1
2
>